Catalyst Pharmaceutical
CPRX
CPRX
259 hedge funds and large institutions have $1.47B invested in Catalyst Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 93 increasing their positions, 84 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 257 → 259 (+2)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3% less capital invested
Capital invested by funds: $1.52B → $1.47B (-$48.7M)
Holders
259
Holding in Top 10
6
Calls
$43M
Puts
$1.76M
Top Buyers
| 1 | +$74.1M | |
| 2 | +$22.8M | |
| 3 | +$18.2M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.52M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.36M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$15.9M | |
| 3 | -$12.3M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$11M |
| 5 |
D.E. Shaw & Co
New York
|
-$7.37M |